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Acoustic Neuroma: Correlation Among Tumor 
Size, Symptoms, and Patient Age
J.P.P.M. van Leeuwen, MD; C.W.R. J. Cremers, MD, PhD; N.RM.W. Thewissen; 
B.S. Harhangi; E. Meijer, MD, PhD
Due to improved diagnostic techniques, acoustic 
neuromas more frequently are detected at an early 
stage. Subsequent treatment depends on such factors 
as expected tumor growth rate, tumor size, and pa­
tient age. The natural history of acoustic neuromas is 
still uncertain:
This study was performed to examine possible 
correlations among tumor size, patient age, signs 
and symptoms, and duration of symptoms. The study 
included 164 patients with an acoustic neuroma who 
were treated at University Hospital Nijmegen, The 
Netherlands, over a period of 13 years. Comparisons 
were made between the findings of this study and the 
reports in the literature. No support was found for 
any of the correlations mentioned in other studies, 
and no relationships could be demonstrated between 
the parameters evaluated in this study. The authors 
therefore recommend that treatment policies be 
based only on well-established correlations.
L a r y n g o s c o p e ,  Vol. 105:701-707,1995
INTRODUCTION
Diagnostic procedures to detect an acoustic neu­
roma have become much more sensitive since the 
introduction of brainstem evoked response audiome­
try, computed tomographic (CT) scanning, and mag­
netic resonance imaging, (MRI) which has further im­
proved sensitivity and specificity. These diagnostic 
procedures also are less difficult on patients than the 
previously used air cisternography. The newer diag­
nostic techniques have sometimes led to the unexpect­
ed diagnosis of an acoustic neuroma in patients with 
only slight symptoms. These visualization techniques 
have also made it possible for physicians to follow 
the growth of an acoustic neuroma before deciding 
whether surgical intervention is necessary. It has re­
cently been established that fairly small differences in 
the size of an acoustic neuroma can influence the oc­
currence of surgical complications.1
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Since many acoustic neuromas now are followed 
using MRI, various questions have arisen about the 
natural history of these tumors. The most important 
questions concern the relationship between tumor 
growth rate, tumor size, and patient age. In addition, 
little is known about the distribution in individual 
growth rates. To answer these questions, it is neces­
sary to perform descriptive studies that focus on possi­
ble correlations between tumor size, signs and symp­
toms, and patient age.
From 1980 through 1992,164 patients underwent 
primary surgery for an acoustic neuroma at the Uni­
versity Hospital Nijmegen, The Netherlands. Using 
the diagnostic data recorded on these patients, the 
authors of this study examined correlations between 
tumor size, signs and symptoms, and patient age. 
Where possible, these findings were compared with 
those reported in a similar study that was performed 
in Copenhagen.2
MATERIALS AND METHODS
From 1980 through 1992, 258 operations for various 
types of space-occupying lesion in the cerebellopontine angle 
were conducted at the University Hospital Nijmegen. This 
study is based on the diagnostic data from the 164 patients 
who were operated on for an acoustic neuroma for the first 
time. In performing the surgeries, the suboccipital approach 
was used in 106 patients, the translabyrinthine, transotic, 
or combined approach was used in 56 patients, and the mid­
dle fossa approach was used in 2 patients. Excluded from the 
study were 36 patients who underwent a second surgery for 
an acoustic neuroma, 54 patients who were operated on for 
other histological diagnoses (N = 54), and 4 patients who 
were known to have central neurofibromatosis type I or II 
and a tumor in the cerebellopontine angle.
Tumor size was determined by a neuroradiologist. The 
maximum diameter of the total tumor was recorded, includ­
ing the intrameatal part. There was a good agreement be­
tween these values and those found during surgery. Data on 
patient sex, patient age at surgery, signs and symptoms, and 
duration of symptoms were collected from the medical files. 
The results of pure-tone audiometry and speech audiometry 
were also collected. In this way, it was possible to examine 
various correlations using linear regression lines between 
tumor size, patient sex, patient age, separate symptoms, du­
ration of symptoms, extent of hearing loss, and speech recog-
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<40 y 
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Patient Aae at the Time an Acoustic Neuroma was Diagnosed: 
Comparison Between the Copenhagen and Nijmegen Sen_.-----
Nijmegen Copenhagen
25%
52%
23%
TABLE 1.
Patient Age
24%
45%
31%
nition In the correlations, the number of patients (N), the 
correlation coefficient W, and the? value are reported.
Unexplained perceptive asymmetry in the pure-tone 
audiogram was the most frequent reason for further otoneu- 
rological investigation. The maximum differences in percep­
tion for the frequencies 0.5,1.0,2.0, and 4.0 kHz were deter­
mined for the patients with a unilateral acoustic neuroma in 
order to establish the extent of asymmetry for at least one 
frequency. This approach gave a practical indication of 
the degree of asymmetry in the hearing loss. Certain levels 
of asymmetry may give rise to the suspicion of an acoustic
neuroma.
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Fig. 1. Mean tumor size, in millimeters, of the acoustic neuromas op­
erated on at University Hospital Nijmegen, The Netherlands, from Jan­
uary 1980 (month 1) through December 1992 (month 156), The study 
included 164 patients; one patient with a tumor measuring 72 mm is 
not shown in this figure. The regression line is y = -0 .084x + 34.
RESULTS
The study group included 88 women and 76 men, 
17 to 79 years of age, with a mean age of 49.2 years. 
The majority of patients were between 40 and 60 years 
of age (Table I). In the literature, the mean age varied 
between 45 and 51 years, with a maximum range of 3 
to 90 years.2-4 The number of patients with an acous­
tic neuroma who were operated on for the first time at 
the University Hospital Nijmegen from 1980 through 
1992 varied from 7 to 20 per year. The mean tumor size 
was 26.5 mm (SD ± 13.2 mm) with a range of 8 to 72 
mm. As shown in Figure 1, the mean tumor size de­
creased gradually but significantly during the study
period (N = 163, r = .279, P = .00034).
The relationship between tumor size and patient 
age at surgery is presented in a scatter diagram (Fig. 
2). No significant correlation was found between tu­
mor size and patient age (N = 164, r = .0054, P = .49), 
since large and small tumors occurred in both young 
and older patients. Tb compare the findings of this 
study with those of the Copenhagen study,2 the tu­
mors were classified into the same three groups ac­
cording to size (i.e., 1 to 25 mm, 26 to 40 mm, and 
greater than 40 mm). The number of patients in each 
group is shown in Table II, The majority of tumors 
were found to occur in natients hptwAPn cmri «n
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Fig. 2. Relationship between patient age at surgery and tumor size for 
the 164 patients in the Nijmegen series.
years of age. For each tumor size, the mean age and 
the male:female ratio were also determined (Table 
III). As tumor size increased, there was a nonsignifi­
cant decrease in mean age, from 50.1 to 45.5 years per 
year, A slightly higher proportion of women had a tu-
Patient
Age
<40 y 
40-60y 
>60 y
TABLE II.
Tumor Size and Patient Age: Comparison Between the Nijmegen and Copenhagen Series.
____ TumorSize
1—25 mm
Nijmegen
(n a 87)
18.4% (16) 
57.5% (50) 
24.1% (21)
Copenhagen 
Ü% 
49% 
39%
26-40 mm >40 mm
Nijmegen 
(n a 60)
33% (20) 
44% (26) 
23% (14)
Copenhagen 
26% 
48% 
26%
All Sizes
Nijmegen
(n=17) Copenhagen
Nijmegen 
(n = 164)
Copenhagen 
(n = 300)
35.3% (6) 31% 25% (41) 24%
47.1% (8) 38% 51.8% (85) 45%
17.6% (3) 31% 14.0% (23) 31%
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TABLE
Tumor
Size
Men
(n = 76)
Women 
(n = 88)
Mean Patient 
Age* SDt
1-25 mm 41 46 50.1 y ±11.8
26-40 mm 28 32 49,2 y ±16.3
>40 mm 7 10 45.5 y ±14.2
+Overall SD was ±14.2.
mor (male:female rate of 1:1.16),
Symptoms of an acoustic neuroma were divided 
into the presenting (main) symptom and all the symp­
toms in the history up to the time of surgery (Table IV). 
The results reported in several other studies were in­
cluded for comparison.2>5~7 The presenting symptom 
in the majority of cases was unilateral hearing loss. 
Less frequent presenting symptoms included tinnitus, 
vertigo, and facial paresthesia. Figure 3 shows an 
overview of the percentage of patients with various 
signs and symptoms per tumor size at the first otologi- 
cal consultation. Small tumors in particular were as­
sociated with hearing loss and tinnitus, while vertigo 
and otalgia were infrequent symptoms. Large tumors 
were associated with headaches, facial parasthesia, 
and ataxia, while eye symptoms and dysarthria were 
less frequent. These findings agreed with those report­
ed in the literature.11
When all the signs and symptoms were analyzed 
together, their incidence changed and other symp­
toms gained more importance (Table V).5,s-io Vari­
ous symptoms were not always mentioned, including 
otalgia, sudden deafness, epilepsy, ataxia, nausea and 
vomiting, and dysarthria. In some studies, vertigo was 
recorded as a symptom, while in others it was sub­
classified into, for example, true vertigo, unsteadi­
ness, and dizziness. This made comparison of the inci­
dence impossible. Tumor size and the duration of the 
first symptom up to the diagnosis are presented in a 
scatter diagram in Figure 4, The symptoms of small 
and large tumors were of both short and long dura­
tion. Therefore, there was no relationship at all be­
tween, for example, a long history of a symptom and
TIN OTALG VISÜS DVSARTR HËADACH VERTIGO SENSÎ0 ATAXIA
Fig. 3. Percentage of different symptoms of an acoustic neuroma re­
lated to tumor size in the 164 patients in the Nijmegen series. The th ree 
categories of tumor size are 1 to 25 mm (white bars), 26 to 40 mm (grey 
bars) and more than 40 mm (black bars). The abbreviations used are 
as follows: HL = hearing loss; TIN = tinnitus; VISUS = eye problems 
such as diplopia; DYSARTR = dysarthria; HEADACH = headaches; 
SENSIB = facial paresthesia.
a large tumor diameter.
Preoperative pure-tone audiometry results were 
available for 158 of the 164 patients. The remaining 6 
patients had been considered neurosurgical emergen­
cies. The mean hearing loss at the frequencies 0.5,1.0, 
and 2.0 kHz (Fletcher index) is shown in Figure 5. 
There was no significant correlation between the level 
of hearing loss and the size of the tumor (N = 158, 
r = .068, P = .40). Small tumors could be associated 
with considerable hearing loss, and large tumors with 
slight hearing loss—all the combinations occurred fre­
quently. When these data were analyzed per tumor 
size (Table VI), the majority of patients (51%) had a 
hearing loss of between 41 and 80 dB, irrespective of 
tumor size.
The difference in hearing thresholds between the 
affected ear and the normal ear was also assessed. The 
largest bone conducting difference was noted per fre­
quency, between 0.5 and 4.0 kHz. As shown in Table 
VII, the mean asymmetry for one frequency was 57.7 
dB (SD ± 23.1 dB). The patients in this study usuall* 
had asymmetrical hearing loss; in 95% of cases, ther * 
was at least a 20-dB difference for one of the frequen­
cies between 0.5 and 4,0 kHz.
A speech audiogram was available for 122 of the 
164 patients. Maximum speech recognition scores 
were determined (Table VIII). In Figure 6, speech
TABLE IV.
Main or 
Presenting 
Symptom
Nijmegen 
Series, 1994 
(N = 164)
Setesnick, 
etai,51993 
(N = 126)
Thomsen 
andTos,21990
(N « 300)
Ellis and 
Wright,61974 
(N = 214)
Ojemann 
et a i,7 1972 
(N = 46)
Hearing loss 73% 50% 75% 71% 73%
Tinnitus 13% 36% 7% 14% 2%
Vertigo/unsteadiness 7% 16% 8% 8% 11%
Facial paresthesia 1% 3% 3% 1% 2%
Headaches 0% 2% — 12% 9%
Sudden deafness 3% •— 7% --------- ----------
Certain symptoms were not mentioned in some studies.
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All Signs and Symptoms of an
TABLE V.
Acoustic Neuroma in the Nijmegen Series and Other Studies
Stgns and 
Symptoms
Hearing loss 
Tinnitus
Vertigo/unsteadiness/ 
dizziness (combined)
Otalgia'otic pressure sensation
Sudden deafness
Headaches
Epilipsy
Ataxia/tremor
Eye symptoms
Paresis of seventh cranial nerve 
Facial paresthesia 
Nausea/vomiting 
Dysarthria
Nijmegen 
Series, 1994 
(N = 164)
93%
57%
29%
12%
3%
24%
4%
33%
7%
5%
22%
3%
3%
Certain symptoms were not mentioned in some studies,
Selesnick, 
etai, 5 1993
(Nr: 126)
85% 
56%
67%
19%
3%
10%
20%
Pfaltz, 
e ia /.,8 l991 
(N = 93)
83%
70%
50%
25%
10%
20%
Wiegand 
and Fickel,9 1989 
(N = 541)
86%
57%
61%
28%
36%
22%
29%
Mathew, 
etai.,101978 
(N = 206)
97%
66%
69%
4%
29%
8%
15%
22%
33%
11%
recognition values and tumor size are presented in a 
scatter diagram. In accordance with the pure-tone au­
diogram, tumor size did not significantly influence 
speech recognition (N = 122, r = .134,P = .14).
DISCUSSION
The fact that there was no clear relationship be­
tween tumor size, signs and symptoms, and the level 
of hearing loss means that even with optimal diagnos­
tic facilities, it is difficult to ensure that all tumors are 
detected in an early, small stage. In reviewing the rela­
tionships between tumor size, level of hearing loss, 
and patient age, the authors of this study found it 
striking that the expected correlations did not exist. It 
would not have been surprising to find a relationship
between tumor size and patient age or between tumor 
size and the level of hearing loss.
An acoustic neuroma can occur at almost any age, 
but most tumors are found in patients 40 to 60 years of 
age. In the present series, 75% of the patients were 
older than 40 years. In younger patients, the symp­
toms may be caused by central neurofibromatosis type
II, which cannot always be recognized immediately. 
The average age of the patients at surgery was similar 
in all series.2»5”10
The size of the tumors operated on at the Uni­
versity Hospital Nijmegen decreased gradually over 
the time period of the study (Fig. 1). The significant 
gradual decrease in mean tumor size per year, from 34
so
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in the Nijmegen series. p
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tumor size (mm)
Fig 5. Degree of sensorineural hearing loss (mean value at 0 5 10
and 2.0 kHz) related to tumor size in 158 of the 164 patients in thé 
Nijmegen series.
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Tumor Size and Hearing Loss in the Pure-Tone Audiogram at 0.5,1.0, and 2.0 Kilohertz (Fletcher Index): 
________________ Comparison Between the Nijmegen and Copenhagen Series.
TABLE VI.
Tumor Size
in the Nijmegen series, the resuits are unknown for 6 patients with a tumor size of 26 to 40 mm.
1--25 mm 26-40 mm >40 mm All Sizes
Fletcher
Index
Nijmegen 
(n = 87)
Copenhagen 
(n = 97)
Nijmegen 
(n = 60)*
Copenhagen 
(n = 85)
Nijmegen
(n=17)
Copenhagen 
(n = 118)
Nijmegen 
(n = 164)
Copenhagen 
(n = 300)
0-20 dB 7% (6) 5% 3% (2) 3% 18% (3) 1% 7% (11) 3%
21-40 dB 29% (25) 13% 22% (13) 21% 24% (4) 14% 26% (42) 16%
41-80 dB 53% (46) 59% 50% (30) 49% 40% (7) 43% 51% (83) 46%
>80 dB 11% (10) 23% 15% (9) 27% 18% (3) 51% 13% (22) 35%
TABLE VII.
The Maximum Difference in Hearing Loss for at Least 
One of the Frequencies from 0.5 to 4.0 Kilohertz as 
Related to Tumor Size in the Nijmegen Series.
Tumor Size Maximum Difference SD
1-25 mm 57.7 dB ' ^ 2 2 ^ 5  dB
26-40 mm 57.1 dB ±20.9 dB
>40 mm 57.3 dB ±31.4 dB
Average 57.5 dB ±23.1 dB
TABLE VIII.
Phoneme Score Related to Tumor Size in the Nijmegen Series.
Maximum
Speech
Recognition
Tumor Size
<26 mm (n = 75) 26-40 mm (n = 31) >40 mm (n » 7)
70-100% 37 (50%) 17 (55%) 9 (56%)
40-69% 25 (33%) 9 (29%) 5(31%)
<40% 13(17%) 5(16%) 2(13%)
mm to 22 mm, is probably due to earlier consulta­
tion with a physician, improved diagnostic techniques, 
and increased awareness of the doctors. In particular, 
MRI has facilitated the early detection of small tu­
mors.
Other authors4’5 also have noted gradually de­
creasing tumor size at presentation in recent years. 
However, the opposite was reported in the Copen­
hagen study,2 which is representative of the whole of 
Denmark. The distribution of patients over the three 
age groups in the present study was very similar to 
that in the Copenhagen series. One striking difference 
was the number of patients with a tumor larger than 
40 mm: 118 patients (33%) in the Copenhagen series 
versus 17 patients (10%) in the Nijmegen series. In 
view of the decrease in the number of large tumors 
found at various centers throughout the world, it may 
be appropriate to interpret the Copenhagen data cau­
tiously, particularly with regard to the existence of cor­
relations, because these correlations may be specific to 
the Danish patient population. External factors that 
influence the size of the tumors referred to a center 
may include, for example, the referral pattern in that 
particular region and the expertise of the surgeon.
An acoustic neuroma can occur at almost any age, 
and the tumor growth rate can vary greatly from indi­
vidual to individual.12 Little is known about the aver­
age growth rate and the distribution in the growth 
rates of acoustic tumors. Whether these tumors grow 
more slowly in older patients also is uncertain. If the 
growth rate remains fairly constant, larger tumors 
generally should be found in elderly patients. No large 
tumors were found in the elderly patients in the pres­
ent study. Various growth rates appear to be possible
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Fig. 6. Phoneme score related to tumor size in 122 of the 164 patients 
in the Nijmegen series.
at all ages, and it seems likely that varying growth 
rates can occur in a single patient. Table III shows that 
the average age of patients with a large tumor de­
creased gradually, although not nonsignificantly, 
against time. However, this study found no correlation 
between tumor size and patient age (Fig. 2).
It is possible that the growth rate varies, depend­
ing on whether the tumor has an isolated nongeneti- 
cally determined etiology or an hereditary etiology, 
such as central neurofibromatosis type I or II. In light 
of recent genetic study results,13 it has become rea­
sonable to assume that a larger proportion of isolated 
cases of acoustic neuroma can be attributed to a chro­
mosomal defect than would be expected on the basis of
Laryngoscope 105: July 1995 van Leeuwen, et ai.: Acoustic Neuroma
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clinical symptoms or family studies. Future gene ic 
studies may provide information that will help predict 
the expected growth rate of an acoustic neuroma.
The symptoms of an acoustic neuroma vaiy, and 
in a retrospective review it is not always possible to 
distinguish clearly between the presenting symptom 
and all the other symptoms. The presenting symp­
tom is usually unilateral deafness—but not in all 
cases. In addition, the percentage of patients with im­
paired hearing as their main symptom was found to 
decrease as tumor size increased (Fig. 3). Therefore, 
tumor size appeared to influence the average com­
plaint pattern. Classifying the symptoms of an acous­
tic neuroma into an audiovestibular stage, a trigemi­
nal stage, or a brainstem stage is too absolute.11 It 
would be better to speak in terms of a gradual shift in 
symptoms (Fig, 3). In the present study, no correlation 
was found between tumor size and the duration of 
symptoms (Fig. 4). In fact, some of the patients with 
very short-term symptoms had large tumors, while 
some of the patients with long-term symptoms had tu­
mors that were mainly restricted to the intrameatal 
site. In contrast, the Copenhagen study2 reported a 
significant relationship between tumor size and symp­
tom duration {P < .05).
Wiegand and Fickel9 surveyed members of the 
American Acoustic Neuroma Association, Therefore, 
their study subjects were recruited using a procedure 
that was different from that employed in other studies 
He., subjects were members of a patient association as 
opposed to patients operated on by the authors of the 
study).
The incidence of hearing loss in the comparison 
studies (67% to 75%)2’5~7 was very similar to that in 
the present series. The symptom distribution in the oth­
er studies was higher for tinnitus (2% to 36%) and ver­
tigo (7% to 16%). Facial paresthesia was only observed 
in 1% to 3% of patients, while sudden deafness and 
headaches were not always mentioned. Some symp­
toms were mentioned infrequently in the literature. 
For instance, ataxia occurred in 33% of the patients in 
this series, but in only 8% of the patients in the study by 
Mathew, et al.10 Symptoms such as sudden deafness 
occurred in only 3% to 4% of patients; however, in one 
study,14 sudden deafness was listed as the presenting 
symptom for small tumors in 19% of patients. If each 
of the possible symptoms of an acoustic neuroma were 
considered an indication for MRI, these tumors could 
be diagnosed much earlier. However, it is questionable 
whether the cost-benefit ratio would remain accept­
able in view of the number of negative diagnoses.
Unilateral hearing loss is the most frequent 
symptom of an acoustic neuroma, but no correlation 
was found between tumor size and the level of hearing 
loss. Deafness was found in patients with tumors of all 
sizes, but relatively good hearing could also be present 
on the affected side. Figure 5 shows that all combina­
tions of tumor size and hearing loss are possible. The
Laryngoscope 105: July 1995
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findings of this study disagreed with those in the 
Copenhagen study,2 which reported a relationship 
between tumor size and hearing loss for large tumors
(P < ,001).
The authors of the present study did find asym­
metry in the hearing loss of the pure-tone audiogram 
of at least 20 dB (average: 57.7 dB). Asymmetrical per­
ceptive hearing loss without any other symptoms is a 
strong indication for further otoneurological tests to 
look for an acoustic neuroma, even though a small pro­
portion of patients with such a tumor will have a nor­
mal pure-tone audiogram. These findings agree with 
those reported in a study performed in Seattle.15 The 
authors of the Seattle study recommended that if the 
average threshold difference at 1 to 8 kHz was 20 dB or 
greater, MRI should be performed on the suspicion of 
an acoustic neuroma. Brainstem evoked response au­
diometry should suffice in patients with an average 
threshold difference of less than 20 dB.
CONCLUSION
Expected correlations among tumor size, symp­
toms, and patient age could not be demonstrated. 
Questions regarding tumor growth rate and the distri­
bution in growth rates remain unanswered. It is not 
possible to say whether there is a relationship be­
tween the moment that a tumor starts to develop and 
the age of the patient; symptoms do not give any reli­
able indication. Since the authors of the present study 
could not demonstrate any of the correlations formerly 
assumed to exist, it would seem appropriate not to 
base the answers to any remaining questions about 
variation in tumor growth rate and the age of the pa­
tient on similar provisional assumptions. This would 
obviously have consequences on otoneurological diag­
nosis and would necessitate repeated cost-benefit 
analyses. Tumor growth rate is still unknown and 
therefore remains a problem in designing the treat­
ment plan for a patient with an acoustic neuroma.
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Benign Essential Blepharospasm is Topic
The Office of Continuing Medical Education and 
UC Davis School of Medicine and Medical Center is 
sponsoring an international conference and scientific 
symposium, “Benign Essential Blepharospasm” on 
September 16 at the Red Lion Hotel in Sacramento,
C alif.
For more information, write to the Office of Con­
tinuing Medical Education, UC Davis School of Medi­
cine, 2701 Stockton Blvd., Sacramento, CA 95817, or 
call (916) 734-5390*
Aesthetic and Reconstructive Rhinoplasty Set
The Manhattan Eye, Ear & Throat Hospital is 
sponsoring a course, “Asethetic and Reconstructive 
Rhinoplasty: An Evaluation of Recent Conceptual and 
Surgical Advances,” November 16-18 at the Plaza Ho­
tel in New York City
The program will cover aesthetic and reconstruc­
tive nasal surgery, examining the latest developments
in technique and technology in addition to live, dual 
screen telecast surgery.
For more information, write to Francine Lein- 
hardt, Manhattan Eye, Ear and Throat Hospital, 210 
E. 64th Street, New York, NY 10021, or call (212) 702- 
7728.
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